AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURGICAL INNOVATIONS GROUP PLC

Declaration of Voting Results & Voting Rights Announcements May 29, 2019

7938_rns_2019-05-29_1ee0c583-82bd-46de-8347-53e9de0fbaca.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5112A

Surgical Innovations Group PLC

29 May 2019

Surgical Innovations Group plc           

("SI Group" or "the Company")

Exercise of Options, PDMR Shareholding & Total Voting Rights

Exercise of Options

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that, on 24 May 2019, it issued and allotted a total of 1,500,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by an employee of the Company.

PDMR Shareholding

The Company announces that, also on 24 May 2019, it issued and allotted a total of 1,500,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by Charmaine Day, Company Secretary and PDMR.  As part of this transaction, Mrs Day sold 1,000,000 shares at a price of 4 pence per share. 

Following this transaction, the beneficial holding of Charmaine Day in the Company is 805,343 shares, representing approximately 0.1% of the issued share capital.

Application will be made to the London Stock Exchange for admission of the 3,000,000 ordinary shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 4 June 2019.  

Total Voting Rights

Following Admission, the Company will have 790,566,177 ordinary Shares in issue with each share carrying the right to one vote. The Company has no ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 790,566,177.

For further information please contact:

Surgical Innovations Group Plc www.sigroupplc.com
Nigel Rogers, Non-Executive Chairman Tel: 0113 230 7597
Melanie Ross, Chief Financial Officer
N+1 Singer (Nominated Advisor and Broker) Tel: 020 7496 3000
Richard Lindley
Rachel Hayes
Walbrook PR (Financial PR & Investor Relations) Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Charmaine Day
2 Reason for the notification
a) Position/status Company Secretary, Surgical Innovations Group plc
b) Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Surgical Innovations Group plc
b) LEI 2138004GHGUH3HUZE156
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p

GB0004016704
b) Nature of the transactions Exercise of 1,500,000 share options ("Exercise")

Sale of 1,000,000 Ordinary Shares of 1p ("Sale")
c) Price(s) and volume(s) Price(s) Volume(s)
In relation to the Exercise:

1.575p

In relation to the Sale:

4p
1,500,000

1,000,000
d) Aggregated information

-     Aggregated volume

-     Price
Not applicable, the Exercise and the Sale were each completed as single transactions

completed as
e) Date of the transactions 24 May 2019
f) Place of the transactions In respect of the Exercise, outside a trading venue

In respect of the Sale, London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCLLFISESIAFIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.